WASHINGTON (MarketWatch) -- A Senate vote on Monday likely assures that U.S. borders will remain shut to lower-priced prescription-drug imports, marking a major victory for pharmaceutical manufacturers.
The Senate voted 49-40 to approve an amendment to a bill dealing with the Food and Drug Administration, which would require the secretary of the Health and Human Services Department to certify that drug imports would pose no safety risk to American consumers before allowing pharmacies to import prescription drugs from Canada and other countries. Health officials have said they can't provide that level of assurance.
Thank god, the drugs from Canada cannot come into our great safe and well protected country! I must have missed those newsflashes about the rampant deaths among the elderly, the children and in general the frail in Canada following ingestion of Canadian drugs...
We all know that the difference between drugs in Canada and the US is just the price (and the profit for the manufacturer). The drug manufacturers are the same in Canada and here, the production standards are the same, the hygiene standards are the same, the pharmacies have the same quality standards! Hey, this is Canada - we are not talking Afghanistan here.
But, the profits are less in Canada, and we cannot let that happen! So, the pharmaceutical companies give a few millions to lobbyists, and voila, the billions of profit continue to go into pharma's pockets.
This is a point where the HMOs should flex their muscle. Where were they when we needed them? Why have they not paid their lobbyists enough? Where were their millions?
This kind of obvious corruption is sad. Laws are maid by the wealthy and for the wealthy. Realistic, but very sad.
You understand now why I do not see pharmaceutical representatives? they get paid by the very same people who pushed this law through. Not only do pharmaceutical reps waste my time, they consistently overcharge my patients. And that is harmful.